Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Current Deferred Revenue (2016 - 2019)

Historic Current Deferred Revenue for Forte Biosciences (FBRX) over the last 4 years, with Q3 2019 value amounting to $9000.0.

  • Forte Biosciences' Current Deferred Revenue fell 7500.0% to $9000.0 in Q3 2019 from the same period last year, while for Sep 2019 it was $9000.0, marking a year-over-year decrease of 7500.0%. This contributed to the annual value of $36000.0 for FY2018, which is 0.0% changed from last year.
  • As of Q3 2019, Forte Biosciences' Current Deferred Revenue stood at $9000.0, which was down 7500.0% from $18000.0 recorded in Q2 2019.
  • Forte Biosciences' Current Deferred Revenue's 5-year high stood at $1.0 million during Q2 2018, with a 5-year trough of $9000.0 in Q3 2019.
  • For the 4-year period, Forte Biosciences' Current Deferred Revenue averaged around $116833.3, with its median value being $36000.0 (2017).
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first surged by 242682.93% in 2018, then plummeted by 9826.25% in 2019.
  • Over the past 4 years, Forte Biosciences' Current Deferred Revenue (Quarter) stood at $45000.0 in 2016, then dropped by 20.0% to $36000.0 in 2017, then changed by 0.0% to $36000.0 in 2018, then crashed by 75.0% to $9000.0 in 2019.
  • Its Current Deferred Revenue was $9000.0 in Q3 2019, compared to $18000.0 in Q2 2019 and $27000.0 in Q1 2019.